Skip to main content
Premium Trial:

Request an Annual Quote

Genaera and Ludwig Institute Extend Collaboration

NEW YORK, March 8 (GenomeWeb News) - Genaera and the Ludwig Institute for Cancer Research said today that they have extended for two years their collaboration to develop genes and proteins as drug targets and therapeutics.

 

"The goal of this collaboration is to provide new therapeutic products for asthma, cancer, and other diseases, based on our combined efforts in genomics and biological research," said Roy Levitt, Genaera's president and CEO, in a statement.

 

The collaboration will include further resarch into interleukin 9, which plays a role in asthma. 

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.